Stockreport

VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma

VBI Vaccines, Inc. - Ordinary Shares  (VBIV) 
Last vbi vaccines, inc. - ordinary shares earnings: 11/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: vbivaccines.com/investors
PDF Data highlighted in oral presentation at World Vaccine Congress 2024 on April 3, 2024Early data from patients eligible for evaluation at week 12 show two observations of [Read more]